Leadership Change

QuanBio Appoints Aubrey C. Galloway, MD, as Chief Medical Officer

2 weeks ago talkbio0Tagged AI-driven, Aubrey C. Galloway, Cardiothoracic surgery specialty, Chief Medical Officer, CMO appointment, Healthcare technology, Leadership Change, medical leadership, QuanBio, Vascular Diseases, vascular intelligence

QuanBio; Aubrey C. Galloway; Chief Medical Officer; CMO appointment; AI-driven vascular intelligence; cardiothoracic surgery; leadership change; healthcare technology; vascular disease; medical leadership

GSK CEO Emma Walmsley Steps Down After 9 Years; Luke Miels to Succeed

4 months ago talkbio0Tagged CEO, Drug Industry, Emma Walmsley, Haleon demerger, Leadership Change, Luke Miels, SmithKline Beecham, specialty medicines, Succession planning, Transition Mutation, Vaccines

Emma Walmsley; GSK; CEO transition; Luke Miels; leadership change; pharmaceutical industry; Haleon demerger; specialty medicines; vaccines; succession planning

Genentech Names Zoë Harris Lazarre as New Chief Marketing Officer as Erica Taylor Moves to Roche Role

4 months ago talkbio0Tagged biotech industry, Chief Marketing Officer, Erica Taylor, genentech, Harris Lazarre, Leadership Change, pharmaceutical marketing, Roche (company), Zoë

Genentech; Chief Marketing Officer; Erica Taylor; Zoë Harris Lazarre; Roche; leadership change; pharmaceutical marketing; biotech industry

Execution, Execution, Execution: Novo’s New CEO Doubles Down on Obesity, Diabetes and Trims Pipeline

6 months ago talkbio0Tagged Diabetes, Glucagon-Like Peptide 1, Incretins, Leadership Change, Market, Maziar Mike Doustdar, Nordisk, Obesity, Ozempic, pipeline, Wegovy

Novo Nordisk; Maziar Mike Doustdar; obesity; diabetes; pipeline cuts; GLP-1 drugs; Wegovy; Ozempic; incretin market; leadership change

Novo Nordisk’s Pipeline Cull Prompts Hopes of Strategic Shift

6 months ago talkbio0Tagged competition, GLP-1/GIP co-agonist, Leadership Change, Market, Nordisk, Obesity, pipeline cull, R&D pipeline, semaglutide, strategic shift, Wegovy

Novo Nordisk; pipeline cull; GLP-1/GIP co-agonist; obesity drugs; leadership change; strategic shift; semaglutide; Wegovy; R&D pipeline; market competition

Novo Nordisk Names Insider Maziar Mike Doustdar as New CEO Amid Growth Challenges

6 months ago talkbio0Tagged Appointments, CEO, Drug Industry, drug market, growth outlook, international operations, Leadership Change, Maziar Mike Doustdar, Nordisk, Obesity

Novo Nordisk; Maziar Mike Doustdar; CEO appointment; leadership change; pharmaceutical industry; growth outlook; obesity drug market; international operations

Genentech’s Kristin Bittenbender Named BIO Board Chair Amid Industry Challenges

7 months ago talkbio0Tagged Bio, biotech industry, Biotechnology, board chair, existential threats, genentech, Kristin Bittenbender, Leadership Change, Policy, United States Food and Drug Administration

BIO; Genentech; Kristin Bittenbender; board chair; biotech industry; FDA; existential threats; leadership change; biotechnology policy

GSK Appoints Sanofi Veteran to Lead Vaccines R&D; Leadership Change at Bristol Myers Corporate Affairs

8 months ago talkbio0Tagged affairs, Corporate, Drug Industry, executive appointment, Gurunathan, Leadership Change, Myers, R&D, Sanjay, sanofi, SmithKline Beecham, squibb, Vaccines

GSK; Sanofi; vaccine R&D; Sanjay Gurunathan; leadership change; pharmaceutical industry; Bristol Myers Squibb; corporate affairs; executive appointment